http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013120275-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 2011-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013120275-A |
| titleOfInvention | PHARMACEUTICAL COMPOSITION |
| abstract | 1. A pharmaceutical composition comprising particulate deferasirox, wherein the particles have an average particle size of less than or equal to approximately 2000 nm. The pharmaceutical composition of claim 1, wherein the particles have an average particle size of less than or equal to about 1000 nm. The pharmaceutical composition according to claim 1, containing at least one excipient. The pharmaceutical composition according to claim 3, wherein the excipient comprises at least one surface stabilizer. The pharmaceutical composition according to claim 3, wherein the excipient comprises at least one thickening agent. The pharmaceutical composition of claim 3, wherein the excipient contains at least one polymer. The pharmaceutical composition of claim 4, wherein the surface stabilizer is a surfactant. The pharmaceutical composition of claim 7, the surfactant is amphoteric, nonionic, cationic or anionic, or combinations thereof. The pharmaceutical composition according to claim 7, wherein the surfactant comprises one or more of polysorbates, sodium dodecyl sulfate (sodium lauryl sulfate), sodium lauryl dimethyl amine oxide, docusate sodium, cetyl trimethyl ammonium bromide (CTAB), oliethoxylated alcohol, polyoxyethylene sorbitan, N-decodecin, octodecidol -oxide, hexadecyl trimethylammonium bromide, polyoxyl 10 lauryl ether, polyoxyethylene ethers (brij), bile salts such as sodium deoxycholate or sodium cholate, castor oil polyoxy, et nonylphenol oxylate, cyclodextrin, lecithin, benzethonium methyl chloride, carboxylate, sulfonate, petroleum sulfonate, alkylbenzenesulfonate, naphthalenesulfonate olefinsulfon |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2695616-C1 |
| priorityDate | 2010-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 163.